• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.36% Nasdaq Up 0.45%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    1.38 Up 0.04(2.99%) 3:59PM EDT
    |After Hours : 1.34 Down 0.02 (1.47%) 4:04PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.34
    Open:1.38
    Bid:1.27 x 200
    Ask:1.47 x 1900
    1y Target Est:1.30
    Beta:0.64
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:1.28 - 1.39
    52wk Range:0.80 - 3.00
    Volume:286,066
    Avg Vol (3m):456,783
    Market Cap:16.79M
    P/E (ttm):N/A
    EPS (ttm):-1.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHUp 2.99%16.79M
    LLYDown 0.15%82.42B
    ONXX 0.00%N/A
    PFEDown 0.23%211.89B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback